Assignee
ULTRAGENYX PHARMACEUTICAL INC
US29 patents
Top patents by PatentIndex Score
US10065981B2Sep 4, 2018
Sialic acid analogs
ULTRAGENYX PHARMACEUTICAL INC4 citations82
US9221858B2Dec 29, 2015
Sialic acid analogs
ULTRAGENYX PHARMACEUTICAL INC4 citations82
US8840926B2Sep 23, 2014
Sialic acid analogs
ULTRAGENYX PHARMACEUTICAL INC8 citations79
US10457701B2Oct 29, 2019
Sialic acid analogs
ULTRAGENYX PHARMACEUTICAL INC1 citations71
US11771748B2Oct 3, 2023
Methods for treating tumor-induced osteomalacia
ULTRAGENYX PHARMACEUTICAL INC1 citations70
US11202822B2Dec 21, 2021
Methods for treating hypophosphatemic disorders
ULTRAGENYX PHARMACEUTICAL INC2 citations70
US10639360B2May 5, 2020
Methods for treating hypophosphatemic disorders
ULTRAGENYX PHARMACEUTICAL INC3 citations70
US9554987B2Jan 31, 2017
Methods and formulations for treating sialic acid deficiencies
ULTRAGENYX PHARMACEUTICAL INC4 citations70
US9241896B2Jan 26, 2016
Methods and formulations for treating sialic acid deficiencies
ULTRAGENYX PHARMACEUTICAL INC4 citations70
US11332438B2May 17, 2022
Creatine prodrugs, compositions and methods of use thereof
ULTRAGENYX PHARMACEUTICAL INC2 citations67
US10385085B2Aug 20, 2019
Crystal forms of sialic acid or salt or solvate thereof
ULTRAGENYX PHARMACEUTICAL INC3 citations63
US10889607B2Jan 12, 2021
Sialic acid analogs
ULTRAGENYX PHARMACEUTICAL INC0 citations61
US12358976B2Jul 15, 2025
Methods for increasing serum concentration of phosphorous and/or 1,25-hydroxy vitamin d
ULTRAGENYX PHARMACEUTICAL INC0 citations60
US12551461B2Feb 17, 2026
Compositions of triglycerides and uses thereof
ULTRAGENYX PHARMACEUTICAL INC0 citations58
US9687532B2Jun 27, 2017
Sialylated glycoprotein compositons and uses thereof
ULTRAGENYX PHARMACEUTICAL INC1 citations58
US9457068B2Oct 4, 2016
Sialylated glycoprotein compositions and uses thereof
ULTRAGENYX PHARMACEUTICAL INC1 citations58
US9457067B2Oct 4, 2016
Sialylated glycoprotein compositions and uses thereof
ULTRAGENYX PHARMACEUTICAL INC1 citations58
US11753369B2Sep 12, 2023
Creatine prodrugs, compositions and methods of use thereof
ULTRAGENYX PHARMACEUTICAL INC1 citations56
US12472268B2Nov 18, 2025
Gene therapy for treating propionic acidemia
ULTRAGENYX PHARMACEUTICAL INC0 citations55
US11377643B2Jul 5, 2022
Therapeutics for glycogen storage disease type III
ULTRAGENYX PHARMACEUTICAL INC1 citations53
US12338450B2Jun 24, 2025
Gene therapy constructs for treating Wilson disease
ULTRAGENYX PHARMACEUTICAL INC0 citations52
US11795473B2Oct 24, 2023
Use of tonicifying agents to enhance recombinant adeno-associated virus yield
ULTRAGENYX PHARMACEUTICAL INC0 citations52
US11898170B2Feb 13, 2024
Cell culture methods involving HDAC inhibitors or rep proteins
ULTRAGENYX PHARMACEUTICAL INC0 citations50
US9937243B2Apr 10, 2018
Sialylated glycoprotein compositions and uses thereof
ULTRAGENYX PHARMACEUTICAL INC0 citations48
US11944658B2Apr 2, 2024
Methods of heat inactivation of adenovirus
ULTRAGENYX PHARMACEUTICAL INC0 citations47
US11013774B2May 25, 2021
Methods of heat inactivation of adenovirus
ULTRAGENYX PHARMACEUTICAL INC0 citations47
US12544437B2Feb 10, 2026
Methods for improved therapeutic use of recombinant AAV
ULTRAGENYX PHARMACEUTICAL INC0 citations46
US12018288B2Jun 25, 2024
Engineered producer cell lines and methods of making and using the same
ULTRAGENYX PHARMACEUTICAL INC0 citations44
US12487152B2Dec 2, 2025
Scalable method for producing transfection reagents
ULTRAGENYX PHARMACEUTICAL INC0 citations42